Fair Value Measurements

12 Months Ended

Mar. 31, 2024

Notes To Financial Statements [Abstract]

19. FAIR VALUE MEASUREMENTS

Fair value is defined as the price that would be received to sell an asset or that would be paid to transfer a liability in an orderly transaction between market participants at the measurement date. We estimate the fair value of financial assets and liabilities using available market information and generally accepted valuation methodologies. The inputs used to measure fair value are classified into three tiers. These tiers include Level 1, defined as observable inputs such as quoted prices in active markets; Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable; and Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring the entity to develop its own assumptions. The following table shows the fair value of our financial assets and liabilities at March 31, 2024 and March 31, 2023:


					Fair Value Measurements
At March 31,	Carrying Value				Quoted Prices in Active Markets for Identical Assets				Significant Other Observable Inputs				Significant Unobservable Inputs
					Level 1				Level 2				Level 3
	2024		2023		2024		2023		2024		2023		2024		2023
Assets:
Cash and cash equivalents	$	207,020	$	208,357	$	207,020	$	208,357	$	—	$	—	$	—	$	—
Forward and swap contracts (1)	208		378		—		—		208		378		—		—
Equity investments (2)	4,767		7,069		4,767		7,069		—		—		—		—
Other investments	2,902		2,066		2,902		2,066		—		—		—		—
Liabilities:
Forward and swap contracts (1)	$	1,014	$	2,054	$	—	$	—	$	1,014	$	2,054	$	—	$	—
Deferred compensation plans (2)	1,186		1,022		1,186		1,022		—		—		—		—
Total debt (3)	3,206,100		3,078,655		—		—		2,895,784		2,754,218		—		—
Contingent consideration obligations (4)	11,000		15,678		—		—		—		—		11,000		15,678

(1) The fair values of forward and swap contracts are based on period-end forward rates and reflect the value of the amount that we would pay or receive for the contracts involving the same notional amounts and maturity dates.

(2) We maintain a frozen domestic non-qualified deferred compensation plan covering certain employees, which allowed for the deferral of payment of previously earned compensation for an employee-specified term or until retirement or termination. Amounts deferred can be allocated to various hypothetical investment options (compensation deferrals have been frozen under the plan). We hold investments to satisfy the future obligations of the plan. Employees who made deferrals are entitled to receive distributions of their hypothetical account balances (amounts deferred, together with earnings (losses)). Changes in the fair value of these investments are recorded in the Interest income and miscellaneous (income) expense line of the Consolidated Statement of Income. During fiscal 2024 and fiscal 2023, we recorded gains (losses) of $1,060 and $(1,176), respectively, related to these investments. In addition, during fiscal 2024 we sold one of our equity investments which had a value of $3,342.

(3) We estimate the fair value of our debt using discounted cash flow analyses, based on our current incremental borrowing rates for similar types of borrowing arrangements. The fair values of our Senior Public Notes are estimated using quoted market prices for the publicly registered Senior Notes.

(4) Contingent consideration obligations arise from prior business acquisitions. The fair values are based on discounted cash flow analyses reflecting the possible achievement of specified performance measures or events and captures the contractual nature of the contingencies, commercial risk, and the time value of money. Contingent consideration obligations are classified in the Consolidated Balance Sheets as accrued expense (short-term) and other liabilities (long-term), as appropriate based on the contractual payment dates.

The changes in Level 3 assets and liabilities measured at fair value on a recurring basis are summarized as follows:


	Contingent Consideration
Balance at March 31, 2022	$	10,550

Additions	8,302
Payments	(80)
Reductions and adjustments	(3,100)
Foreign currency translation adjustments	6
Balance at March 31, 2023	$	15,678
Additions	1,313
Payments	(5,967)

Foreign currency translation adjustments	(24)
Balance at March 31, 2024	$	11,000

Additions of contingent consideration obligations during fiscal year 2024 and 2023 were primarily related to our fiscal year 2024 and 2023 acquisitions. Payments of contingent consideration obligations during fiscal year 2024 were primarily related to payouts from prior period acquisitions. Adjustments are recorded in the Selling, general, and administrative expenses line of the Consolidated Statements of Income. Refer to Note 3 titled, "Business Acquisitions and Divestitures" for more information.

Fair Value, Measurement Inputs, Disclosure [Table Text Block]

The following table shows the fair value of our financial assets and liabilities at March 31, 2024 and March 31, 2023:


					Fair Value Measurements
At March 31,	Carrying Value				Quoted Prices in Active Markets for Identical Assets				Significant Other Observable Inputs				Significant Unobservable Inputs
					Level 1				Level 2				Level 3
	2024		2023		2024		2023		2024		2023		2024		2023
Assets:
Cash and cash equivalents	$	207,020	$	208,357	$	207,020	$	208,357	$	—	$	—	$	—	$	—
Forward and swap contracts (1)	208		378		—		—		208		378		—		—
Equity investments (2)	4,767		7,069		4,767		7,069		—		—		—		—
Other investments	2,902		2,066		2,902		2,066		—		—		—		—
Liabilities:
Forward and swap contracts (1)	$	1,014	$	2,054	$	—	$	—	$	1,014	$	2,054	$	—	$	—
Deferred compensation plans (2)	1,186		1,022		1,186		1,022		—		—		—		—
Total debt (3)	3,206,100		3,078,655		—		—		2,895,784		2,754,218		—		—
Contingent consideration obligations (4)	11,000		15,678		—		—		—		—		11,000		15,678

- Definition

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References + Details